🔎 Trials Near Me

Akèy › Maladi poumon entèstisyèl › Florid

Etid klinik pou Maladi poumon entèstisyèl nan Florid

25 etid pou Maladi poumon entèstisyèl ap chèche patisipan nan sit nan Florid.

Vil nan Florid

Tèks ofisyèl etid la (Anglè)

FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression

  • Clinical Research Specialists LLC - Kissimmee, Kissimmee
  • Lakeland Regional Medical Center - Lakeland, Lakeland
  • Advanced Pulmonary Research Institute, Loxahatchee Groves
  • ak 4 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT07540988

A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis

  • Clinical Research Specialists LLC - Kissimmee, Kissimmee
Ap rekriteFaz 3
Laj 40 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07201922

Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  • USA017, Gainesville
  • USA006, Naples
  • USA026, St. Petersburg
  • ak 1 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07179380

LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  • University of Florida, Gainesville
  • New Access Research and Medical Services, Miami
  • Eunix Clinical Research, Orlando
  • ak 1 plis
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 29, 2026 · NCT05798923

A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases

  • Meris Clinical Research-Brandon-69466, Brandon
  • Miami VA Healthcare System, Miami
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT06806592

A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)

  • Clinical Research Site, Kissimmee
Ap rekriteFaz 3
Laj 18 a 85 · Tout sèks · Mizajou Sep 11, 2026 · NCT07816185

A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

  • GSK Investigational Site, Jacksonville
  • GSK Investigational Site, Miami
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT05878717

A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease

  • GSK Investigational Site, Gainesville
  • GSK Investigational Site, Naples
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT06572384

A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

  • Cleveland Clinic Florida, Weston
Ap rekriteFaz 2
Laj 40 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT06968845

A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

  • Clinical Research Site, Kissimmee
Ap rekriteFaz 2
Laj 18 a 85 · Tout sèks · Mizajou Sep 2, 2026 · NCT07333183

A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD

  • Tampa General Hospital, Tampa
Ap rekriteFaz 3
Laj 18 a 80 · Tout sèks · Mizajou Sep 2, 2026 · NCT07285655

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  • University of Florida, Gainesville
  • NCH Research Institute, Naples
  • Advent Health Medical Group Advanced Lung Disease, Orlando
  • ak 3 plis
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 26, 2026 · NCT06388421

Emapalumab MDA5 Rapidly Progressive Interstitial Lung Disease (RP-ILD) Study

  • University of Miami Hospital and Clinics, Miami
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Aug 25, 2026 · NCT07486869

RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis

  • Mayo Clinic Florida, Jacksonville
Ap rekriteFaz 2/3
Laj 18 a 75 · Tout sèks · Mizajou Aug 17, 2026 · NCT06328777

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

  • University of Florida, Gainesville
  • University of South Florida, Tampa
Ap rekriteEtid obsèvasyon
Laj 21 ak plis · Tout sèks · Mizajou Aug 12, 2026 · NCT01915511

A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)

  • Mayo Clinic of Florida, Jacksonville
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Aug 10, 2026 · NCT07175038

Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease

  • University of South Florida, Tampa
Ap rekriteFaz 2
Laj 4 ak plis · Tout sèks · Mizajou Jul 22, 2026 · NCT04925375

Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

  • Ascension Medical Group St. Vincent's Lung Institute, Jacksonville
  • Mayo Clinic, Jacksonville
  • TGH/USF Center for Advanced Lung Disease and Lung Transplant, Tampa
  • ak 1 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Jul 13, 2026 · NCT05943535

An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

  • Advent Health, Orlando
  • Tampa General Hospital Center of Research Excellence, Tampa
Ap rekriteEtid obsèvasyon
Laj 18 a 80 · Tout sèks · Mizajou Jun 26, 2026 · NCT06129240

Home-based Pulmonary Rehabilitation and Health Coaching in Patients With Fibrotic Interstitial Lung Disease

  • Mayo Clinic in Florida, Jacksonville
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Mar 20, 2026 · NCT06751069

Nebulized Human Amniotic Fluid in Patients With Interstitial Lung Disease

  • Maule Stem Cell Research Institute, Venice
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jan 29, 2026 · NCT07372989

Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis

  • Florida Lung Asthma and Sleep Specialist, Celebration
  • Central Florida Pulmonary Group, P.A. (CFPG) - Downtown Orlando, Orlando
Ap rekriteFaz 2
Laj 40 ak plis · Tout sèks · Mizajou Nov 12, 2025 · NCT05975983

Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)

  • aTyr Investigative Site, Miami
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou May 7, 2025 · NCT05892614

Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.